Skip to content
Sampre Nutritions logo

Sampre Nutritions

530617 BSE
Price unavailable

Sampre Nutritions (SAMPRE) share price was ₹4.24 at the 28 Oct 2026 close; market capitalisation ₹40.28 Cr; P/E (TTM) 11.16; sector Food Products. The share price fell 89.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 36.6% year on year to ₹14.85 Cr and net profit was ₹0.70 Cr, against ₹0.71 Cr a year earlier (compared with Jun 2025). Promoters held 14.04% of Sampre Nutritions in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 45/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹4.24 −34.84 −89.15% 1Y

Key Fundamentals

MicrocapFood ProductsFMCG
Market Cap
₹40.28 Cr
P/E (TTM)
11.16
EBITDA
₹5.20 Cr
Return on Equity
2.87%
Debt to Equity
0.17
Book Value
₹11.30
EPS (TTM)
₹0.38
52W High
₹38.95
52W Low
₹4.19

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Consolidated · TTM

Peer Comparison

Fast Moving Consumer Goods › Food Products › Packaged Foods

Nestle
₹1,174.2058.622,26,423 Cr39.191.19%67.85%56.08%25,744 Cr3,860 Cr
Britannia Industries
₹4,649.5043.011,11,992 Cr21.931.98%49.40%61.27%19,516 Cr2,610 Cr
Zydus Wellness
₹467.7579.0114,882 Cr2.550.25%3.38%3.43%4,519 Cr188 Cr
Bikaji Foods International
₹459.3042.5311,516 Cr7.170.27%14.90%19.20%3,073 Cr272 Cr
Bombay Burmah Trading
₹1,197.906.488,358 Cr1.191.44%26.04%34.71%20,089 Cr2,585 Cr
Mrs. Bectors Food
₹183.2837.875,627 Cr4.430.70%11.08%13.93%2,152 Cr149 Cr
Gopal Snacks
₹242.5036.033,023 Cr6.310.41%15.38%20.75%1,652 Cr84 Cr
Sampre Nutritions (this company)
—11.1640 Cr0.380.00%2.87%2.62%48 Cr4 Cr
Median 8 companies₹467.7540.209,937 Cr5.370.55%15.14%19.98%3,796 Cr230 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

45 Average
Overall score

Data confidence 100/100

Category scores

Quality Weak 44
Returns, margins, earnings quality 22% weight
Valuation Average 49
Cheap vs sector & own history 24% weight
Growth Strong 92
Sales & profit trajectory 9% weight
Financial Health Average 50
Solvency, leverage, coverage 9% weight
Momentum Poor 3
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Stock is trading at 0.54 times its book value
  • Company is expected to give good quarter

Weaknesses

4
  • Promoter holding is low: 14.0%
  • Company has a low return on equity of -2.45% over last 3 years.
  • Promoter holding has decreased over last 3 years: -23.0%
  • Working capital days have increased from 50.4 days to 71.6 days

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

Bearish

Bearish
12
Neutral
4
Bullish
3

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
71.76% higher than 3Y

change over 1 year

Net Income Growth
-140% lower than 3Y

change over 1 year

Cash Flow Change
—

EBITDA Margin Change
-187%

change over 1 year Operating margin 10.1% · Jun 2026

Quarterly Results

Particulars Jun 2010Sep 2010Dec 2010Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
2.61
1.25
2.95
4.76
4.51
7.27
5.58
7.77
10.87
10
7.39
15.1
14.85
Expenses
2.42
0.8
2.58
2.73
3.56
6.26
5.14
14.04
9.49
8.06
5.91
14.67
13.35
Operating Profit
0.19
0.45
0.37
2.03
0.95
1.01
0.44
-6.27
1.38
1.94
1.48
0.43
1.5
OPM %
7.28%
36%
12.54%
42.65%
21.06%
13.89%
7.89%
-80.69%
12.7%
19.4%
20.03%
2.85%
10.1%
Other Income
0
0
0
0.09
0.03
0
0.04
0.31
0.03
0.01
0
0.67
0.07
Interest
0.07
0.19
0.16
0.48
0.45
0.45
0.59
0.58
0.31
0.28
0.26
0.51
0.26
Depreciation
0.11
0.2
0.19
0.92
0.44
0.44
0.44
0.66
0.39
0.61
0.5
0.54
0.51
PBT
0.01
0.06
0.02
0.72
0.09
0.12
-0.55
-7.2
0.71
1.06
0.72
0.05
0.8
Tax %
0%
0%
0%
36.11%
0%
0%
0%
2.08%
0%
16.04%
13.89%
-2600%
12.5%
Net Profit
0.01
0.06
0.02
0.47
0.1
0.12
-0.54
-7.35
0.71
0.9
0.62
1.35
0.7
EPS (₹)
0.01
0.03
0.01
0.16
0.03
0.03
-0.08
-0.88
0.08
0.1
0.07
0.14
0.07
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
37.11
25.15
25.12
43.35
47.34
Expenses
33.05
21.03
28.97
38.57
41.99
Operating Profit
4.06
4.12
-3.85
4.78
5.35
OPM %
10.94%
16.38%
-15.33%
11.03%
11.3%
Other Income
0.07
0.12
0.37
0.43
0.75
Interest
1.89
1.92
2.07
1.39
1.31
Depreciation
1.82
1.83
1.97
2.05
2.16
PBT
0.42
0.49
-7.52
1.77
2.63
Tax %
16.67%
53.06%
1.99%
-73.45%
—
Net Profit
0.35
0.23
-7.67
3.08
3.57
EPS (₹)
0.13
0.08
-0.91
0.32
0.38
Div. Payout %
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6.87
7.27
21.01
47.5
Reserves
14.29
15.2
69.87
59.85
Borrowings
16.77
17.5
16.9
17.91
Other Liabilities
5.66
4.78
7.65
9.12
Total Liabilities
43.59
44.75
115
134
Fixed Assets
20.52
21.06
19.86
20.1
CWIP
4.16
5.5
5.01
5.01
Investments
0.01
0.01
73.51
83.47
Other Assets
18.9
18.18
17.05
25.8
Total Assets
43.59
44.75
115
134
Figures in ₹ Crores

Cash Flow

Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.88
3.95
0.08
-1.1
Investing
-4.32
-3.7
-75.17
-2.75
Financing
3.48
-0.09
75.03
3.7
Net Cash Flow
0.04
0.16
-0.05
-0.15
Free Cash Flow
-3.44
0.24
-0.2
-3.39
CFO/OP
28
91
-5
-23
Figures in ₹ Crores

Ratios

Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
73.47
97.53
129
112
Inventory Days
169
552
249
186
Days Payable
92.15
150
199
135
Cash Conversion Cycle
150
500
179
163
Working Capital Days
49.37
50.36
29.35
71.65
ROCE %
—
6.19%
-7.38%
2.71%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sampre Nutritions insights

59 extracted metrics + investor summaries across FY08–FY27.

Shareholding Pattern

Public45.36%Promot.14.04%Others40.60%As ofSep 2026

Documents

Frequently Asked Questions about Sampre Nutritions

What does Sampre Nutritions Ltd do?
Incorporated in 1991, Sampre Nutrition Ltd is in the business of manufacturing sugar boiled candies & toffees.[1]
Where is Sampre Nutritions Ltd (SAMPRE) listed?
Sampre Nutritions Ltd trades under code 530617 on the BSE.
Which sector does Sampre Nutritions Ltd belong to?
Sampre Nutritions Ltd is classified under the Food Products sector, in the Packaged Foods industry.
What is the market capitalisation of Sampre Nutritions Ltd?
Sampre Nutritions Ltd has a market capitalisation of ₹40.28 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Sampre Nutritions Ltd?
Sampre Nutritions Ltd trades at a PE ratio of 11.16 as of 28 Oct 2026, on earnings per share of ₹0.38, against a book value of ₹11.3 per share.
What is the 52-week high and low of Sampre Nutritions Ltd?
Over the last 52 weeks Sampre Nutritions Ltd has traded between ₹4.19 and ₹38.95 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Sampre Nutritions Ltd?
Sampre Nutritions Ltd reported a return on equity of 2.87%. Its debt-to-equity ratio is 0.17.

Company Information

Incorporated in 1991, Sampre Nutrition Ltd is in the business of manufacturing sugar boiled candies & toffees.[1]

Website sampreltd.com
Face Value ₹ 5
Shares Outstanding 9,49,89,562

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530617.md for Sampre Nutritions Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Food Processing stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month